Past year: ▼ 10%(12.90 – 18.68 AUD)
Each one in plain English, with the numbers worked through for a shareholder.
8 Feb 2024drilling scheduled▲ Good
NexGen began a 30,000m 2024 exploration drill program, up from 22,114m drilled in 2023, with up to four rigs: 15,700m at SW2 (Rook I) and 14,300m at SW1. Cash was about C$410 million. Federal permitting remains the priority.
5 Feb 2024other● Neutral
January 2024 monthly securities statement: ASX-quoted CDIs rose to 44,016,772 from 37,300,876 via transfers. Common shares not in CDIs rose to 494,832,886; options 51,057,469. Administrative.
4 Jan 2024other● Neutral
December 2023 monthly securities statement: ASX-quoted CDIs rose to 37,300,876 from 34,650,252 through transfers from TSX/NYSE shares. Options rose to 51,565,802; debenture convertible shares unchanged at 16,272,189. Administrative.
12 Dec 2023capital raising announcement● Neutral
The 11 December 2023 equity distribution agreement with Virtu ITG Canada and Virtu Americas sets up the at-the-market program for up to C$500M of shares. This is the legal document behind the renewal already announced; no new terms are shown in the readable text.
12 Dec 2023capital raising announcement● Neutral
Prospectus supplement dated 11 December 2023 qualifies sale of up to C$500M of common shares through Virtu agents, in Canada and the US. It is not offered in Australia. Repeats the already announced ATM renewal; no new amounts.
12 Dec 2023capital raising announcement● NeutralMajor
NexGen renewed its at-the-market share program, now up to C$500M (up from C$250M), with Virtu, running to 8 January 2026. The January 2023 agreement was terminated. Shares sell at market price, so more dilution is possible; proceeds fund development, exploration and general purposes.
12 Dec 2023other● Neutral
Blake, Cassels & Graydon LLP consent to the reference to its legal opinion in the 11 December 2023 prospectus supplement. Routine consent; no new information.
12 Dec 2023capital raising announcement● Neutral
ASX cleansing prospectus lodged 12 December 2023, offering one CDI at A$10.50 (raising A$10.50). It is a technical device so shares issued, such as under the ATM, can be freely resold on ASX; not a real fundraising.
12 Dec 2023other● Neutral
Farris LLP consent to the reference to its name and opinion in the 11 December 2023 prospectus supplement. Routine consent; no new information.
11 Dec 2023other● Neutral
Kevin Small's consent, as a qualified person and Senior VP Operations and Engineering, to use of his reviewed technical information in the 8 December 2023 prospectus. Routine consent; no new data.
11 Dec 2023other● Neutral
Director Trevor Thiele's standard form appointing NexGen as agent for service of process in Canada, tied to the 8 December 2023 prospectus. Administrative; no new information.
11 Dec 2023other● Neutral
SLR International's consent, signed by Mark Mathisen, to use of Arrow feasibility study information in the 8 December 2023 prospectus. Routine consent; no new data.
11 Dec 2023capital raising announcement● Neutral
Final C$500M short form base shelf prospectus dated 8 December 2023, allowing shares, warrants, units, subscription receipts and debt to be sold over 25 months. It replaces the preliminary version; no specific raising or price is set yet.
11 Dec 2023other● Neutral
KPMG consents to its 24 February 2023 audit report on the 2022 and 2021 financial statements being incorporated into the 8 December 2023 prospectus. Routine consent; no new financial information.
11 Dec 2023other● Neutral
Mark Hatton's consent, as a qualified person, to use of Arrow feasibility study information (February 2021, amended March 2021) in the 8 December 2023 prospectus. Routine consent; no new data.
11 Dec 2023other● Neutral
Director Donald Roberts's standard form appointing NexGen as agent for service of process in Canada, tied to the 8 December 2023 prospectus. Administrative; no new information.
11 Dec 2023other● Neutral
Director Warren Gilman's standard form appointing NexGen as agent for service of process in Canada, tied to the 8 December 2023 prospectus. Administrative; no new information.
11 Dec 2023other● Neutral
British Columbia Securities Commission receipt, also covering Ontario, for the final base shelf prospectus dated 8 December 2023. Regulatory paperwork with no new facts.
11 Dec 2023other● Neutral
Chair Christopher McFadden's standard form appointing NexGen as agent for service of process in Canada, tied to the 8 December 2023 prospectus. Administrative; no new information.
11 Dec 2023other● Neutral
Paul O'Hara's consent, as a qualified person, to use of Arrow feasibility study information in the 8 December 2023 prospectus. Routine consent; no new data.
11 Dec 2023other● Neutral
Exploration Manager Jason Craven's consent, as a qualified person, to use of his reviewed technical information in the 8 December 2023 prospectus. Routine consent; no new data.
5 Dec 2023other● Neutral
November 2023 monthly securities statement: ASX CDIs rose about 5.6m to 34,650,252 through transfers. Common shares not in CDIs fell to 488,176,470 and options to 48,450,802. Debenture securities unchanged at 16.27m. Administrative.
4 Dec 2023capital raising announcement● Neutral
Preliminary filing dated 1 December 2023 for a new C$500M base shelf prospectus (shares, warrants, units, debt and more) over 25 months. It is not yet final, and not offered in Australia. Presumably renews the existing shelf (inference); no raising yet.
4 Dec 2023other● Neutral
British Columbia Securities Commission receipt, also covering Ontario, for the preliminary base shelf prospectus dated 1 December 2023. Regulatory paperwork with no new facts.
4 Dec 2023other● Neutral
CFO Benjamin Salter's certificate that NexGen meets the criteria to file a short form base shelf prospectus, dated 1 December 2023. Compliance paperwork with no new information.
21 Nov 2023investor presentation● Neutral
NexGen announced a Q3 conference call on 22 November 2023 to update on the 100%-owned Rook I Project. Topics include the provincial environmental approval, federal permitting status, the confirmation program and recent financing. A notice of a call, with no new results.
10 Nov 2023regulatory community update▲ GoodMajor
NexGen received Saskatchewan ministerial environmental assessment approval to develop its 100%-owned Rook I project, stated to be the first such uranium approval in the province in over 20 years. This resolves the provincial review; federal responses are all submitted.
6 Nov 2023other● Neutral
October 2023 monthly securities statement: ASX CDIs rose about 2.6m to 29,070,082 through transfers. Common shares not in CDIs fell to 493,203,306. Debenture-related securities were unchanged at 16.27m. Administrative.
3 Nov 2023half year report● Neutral
Unaudited September 2023 nine-month statements: cash rose to C$370.4m from C$134.4m at December 2022, helped by the debenture financing and at-the-market sales. Convertible debentures were C$189.2m. Nine-month net loss was C$89.8m. Total equity C$664.7m.
3 Nov 2023other● Neutral
CEO Leigh Curyer's standard certification of the September 2023 interim filings. Compliance paperwork with no new information.
